Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts
Abstract Prognostic biomarkers serve a variety of purposes in cancer treatment and research, such as prediction of cancer progression, and treatment eligibility. Despite growing interest in multi-omic data integration for defining prognostic biomarkers, validated methods have been slow to emerge. Gi...
Guardado en:
Autores principales: | Jeffrey A. Thompson, Brock C. Christensen, Carmen J. Marsit |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4595189a82f94bd59ee0359b5de48c2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of radiation dose intensity with overall survival in patients with distant metastases
por: Johnny Kao, et al.
Publicado: (2021) -
The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Bin Xu MD, et al.
Publicado: (2021) -
Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer
por: G.C Deng, et al.
Publicado: (2021) -
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
por: Forsythe A, et al.
Publicado: (2018) -
Survival analysis in plant pathology
por: Nunes Nesi,Cristiano, et al.
Publicado: (2013)